GeneDx Holdings Corp. Balance Sheet
WGS / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
GeneDx Holdings Corp. had $524M in total assets and $308M in shareholders' equity as of FY2025. Total debt was $55M against $105M in cash, resulting in a $50M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $105.0M | $85.2M | $99.7M | $123.9M | $400.6M | $108.1M | - |
| Accounts Receivable | $74.4M | $37.6M | - | $42.6M | $26.5M | $32.0M | - |
| Inventory | $14.0M | $10.7M | $8.8M | $13.7M | $33.5M | $25.0M | - |
| Current Assets | $268.3M | $198.0M | $182.3M | $212.6M | $483.5M | $174.1M | - |
| PP&E (Net) | $45.7M | $32.9M | $32.5M | $51.5M | $62.7M | $63.1M | - |
| Goodwill | $13.5M | $0 | - | - | $0 | $0 | - |
| Total Assets | $523.7M | $419.4M | $418.8M | $490.9M | $554.1M | $251.6M | - |
| Current Liabilities | $108.9M | $54.8M | $58.8M | $144.3M | $101.3M | $73.4M | - |
| Total Debt | $54.5M | $55.8M | $56.3M | $11.0M | $11.0M | $19.0M | - |
| Shareholders' Equity | $308.2M | $245.2M | $228.0M | $253.7M | $388.1M | -$330.1M | -$88.7M |